|
We fund solutions that help men living with prostate cancer today.The PCF was created by a group of oncologists to invest in what we call “treatment innovation research.” This is a type of clinical research, that is research that is done using people as the research subject, not rats or cell lines. This research takes known treatment methods and innovates to produce breakthroughs for men within 4-6 years. Specifically, our aim is to achieve higher cure rates with fewer side effects.
Currently, only 3-4% of national prostate cancer funding is devoted to clinical research as a whole. This makes it almost impossible for talented clinicians to get funding for treatment innovation. PCF is the only organization in Canada dedicated to funding this kind of research. Men with prostate cancer live an average of 15 years before the disease begins to threaten their lives. Treatment innovation is the key to finding a cure for them rather than a possible new therapy for their sons courtesy of basic research. |
We’re also on a mission to find “a cure without compromise.” |
A lot of men, when first diagnosed with prostate cancer, are more concerned about becoming impotent than they are about dying. And, as a consequence, too many decline to be treated. Unfortunately this is a very real threat. Historically, about 50% of men treated for prostate cancer suffer from erectile dysfunction. Our goal at PCF is to achieve higher cure rates with fewer side effects, so that men have a better chance at re-establishing their pre-treatment sexual function. In addition to reduced rates of erectile dysfunction, we have shown that reduced rates of urinary and bowel issues are possible. Our SABR Prostate Trial is a good example of research into a cure without compromise.
|
Dr. Andrew Loblaw, MD Chair Professor of Radiation Oncology, University of Toronto Clinician Scientist and GU site Group Lead Department of Radiation Oncology Sunnybrook Health Sciences Centre Education Doctor of Medicine Queen’s University Kingston, Ontario |
John Blanchard Managing Director Retired CEO, Prostate Cancer Canada Education Bachelor of Arts Queen’s University Kingston, Ontario |
Lawrie Kaplan Treasurer Retired CFO Three Large GTA Hospitals Professional Qualifications Chartered Accountant |
Business Number: 805140951RR0001
|
Site |
© 2016 Prostate Cure Foundation
|